← Back to Search

FEED-FF for Colorectal Cancer

N/A
Recruiting
Led By Doratha (Armen) Byrd, PhD, MPH
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, week 6.5 and up to 12.5 weeks
Awards & highlights

Study Summary

"This trial aims to see if a special diet with fermented foods can help rectal cancer patients undergoing treatment and if they find it easy to follow."

Who is the study for?
This trial is for individuals with locally advanced rectal cancer who are about to receive chemoradiotherapy. Participants should be willing to follow a special diet that includes fermented foods and meet other study requirements.Check my eligibility
What is being tested?
The FEED Trial is testing the effects of a high-fermented food diet (FEED-FF) on patients with rectal cancer during their standard chemoradiotherapy treatment, aiming to see if it can improve outcomes.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include digestive discomfort or changes in bowel habits due to the introduction of fermented foods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, week 6.5 and up to 12.5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, week 6.5 and up to 12.5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effects of FEED-FF diet on local immune-related biomarkers
Effects of FEED-FF diet on quality of life
Effects of FEED-FF diet on the gut microbiome
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FEED-FFExperimental Treatment1 Intervention
Participants will be asked to pick up the fermented foods at the Research Kitchen at Moffitt. Participants will be asked to eat 3-6 servings of FFs per day, from 1 week prior to treatment start through 12 weeks after treatment start/until the restaging scope is completed. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints. After the dietary intervention, participants will be asked to complete an exit survey to provide feedback on the study and intervention.
Group II: Standard of Care (SUC)Active Control1 Intervention
Participants will receive general healthy eating handouts similar to current usual care documents provided in clinic. These handouts will detail typical healthy foods and the suggested level of intake, or servings per day. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints.

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
543 Previous Clinical Trials
135,452 Total Patients Enrolled
Doratha (Armen) Byrd, PhD, MPHPrincipal InvestigatorMoffitt Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals being enlisted for participation in this study?

"Indeed, the details on clinicaltrials.gov indicate that this investigation is presently in search of volunteers. The initial posting date was 2/19/2024 with the latest update noted on 3/22/2024. This study aims to enroll a total of 30 participants at a single designated site."

Answered by AI

Are there any ongoing opportunities for patients to participate in this medical trial?

"Indeed, the details on clinicaltrials.gov affirm that this study is presently seeking suitable candidates. Initially shared on February 19th, 2024, and most recently revised on March 22nd, 2024, the research aims to recruit a total of 30 participants from one designated site."

Answered by AI
~20 spots leftby Mar 2027